NCT00959621View on ClinicalTrials.gov

Low Molecular Weight Heparin and/or Aspirin in Prevention of Habitual Abortion

PHASE3CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2008

Conditions
Habitual Abortion
Interventions
DRUG

Aspirin

ASA 100 mg once daily per os

DRUG

Klexane

Klexane 40 mg sc once daily (HABENOX 1 and 2), Klexane 40 mg twice daily in HABENOX 3

DRUG

Klexane and ASA

Klexane 40 mgx 1 sc and ASA 100 mg po

Trial Locations (1)

00290

Helsinki University Hospital, Helsinki

All Listed Sponsors
collaborator

Oulu University Hospital

OTHER

collaborator

Karolinska University Hospital

OTHER

collaborator

Leiden Hospital, Leiden, The Netherlands

UNKNOWN

lead

University of Helsinki

OTHER

NCT00959621 - Low Molecular Weight Heparin and/or Aspirin in Prevention of Habitual Abortion | Biotech Hunter | Biotech Hunter